Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1.
Ho-Fai ChauYue WuWan-Yiu FokWaygen ThorWilliam Chi Shing ChoPing'an MaJun LinNai-Ki MakJean-Claude G BünzliLijun JiangNicholas J LongHong Lok LungKa-Leung WongPublished in: JACS Au (2021)
A lanthanide-based peptide-directed bioprobe LnP19 (Ln = Eu or Yb) is designed as an impressive example of a small molecule-based dual-functional probe for the EBV oncoprotein LMP1. The peptide P19 (Pra-KAhx-K-LDLALK-FWLY-K-IVMSDKW-K-RrRK) is designed to selectively bind to LMP1 by mimicking its TM1 region during oligomerization in lipid rafts while signal transduction is significantly suppressed. Immunofluorescence imaging and Western blotting results reveal that P19 can effectively inactivate the oncogenic cellular pathway nuclear factor κB (NF-κB) and contribute to a selective cytotoxic effect on LMP1-positive cells. By conjugation with cyclen-based europium(III) and ytterbium(III) complexes, EuP19 and YbP19 were constructed to offer visible and near-infrared LMP1-targeted imaging and cancer monitoring. In addition to the ability to target and inhibit LMP1 and to selective inhibit LMP1-positive cells, selective growth inhibition toward the LMP1-positive tumor by LnP19 is also demonstrated.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- nuclear factor
- small molecule
- high resolution
- induced apoptosis
- toll like receptor
- cell cycle arrest
- signaling pathway
- oxidative stress
- wastewater treatment
- immune response
- cell proliferation
- cell death
- cancer therapy
- mass spectrometry
- genome wide
- south africa
- fatty acid
- photodynamic therapy
- transcription factor
- inflammatory response
- endoplasmic reticulum stress
- young adults
- metal organic framework
- living cells